Skip to main content
Journal cover image

Safety of Percutaneous Biopsy for Hepatic Angiosarcoma: Results of a Multicenter Korean Survey.

Publication ,  Journal Article
Kang, TW; Lee, MW; Choi, D; An, C; Kim, M-J; Joo, I; Lee, SJ; Lim, S; Park, JG; Seo, JW; Jung, S-H
Published in: J Vasc Interv Radiol
June 2016

PURPOSE: To evaluate the incidence of severe bleeding and mortality associated with percutaneous biopsy for hepatic angiosarcoma in a multicenter retrospective cohort. MATERIALS AND METHODS: A retrospective review of 33 patients with biopsy-proven hepatic angiosarcoma (29 male; median age, 57 y; age range, 24-96 y) was performed at seven tertiary academic hospitals between January 1998 and March 2015. The mean maximum tumor size was 5.5 cm (range, 1.7-20 cm). An 18-gauge automated cutting biopsy needle was used with a freehand technique in all patients who underwent ultrasonography-guided percutaneous core needle biopsy on an inpatient basis. The incidences of severe bleeding and procedure-related mortality were evaluated per Society of Interventional Radiology (SIR) guidelines. RESULTS: There was a mean of 2.8 needle passes per patient during the procedure (range, 1-6). The overall incidence of severe bleeding events (SIR grade C/D) was 9.1% (3 of 33). Two patients were managed with blood transfusion, and one patient underwent embolization for bleeding control. No other major complications were encountered. There were no cases of mortality associated with the biopsy. CONCLUSIONS: Severe bleeding was not a frequent complication after percutaneous biopsy for hepatic angiosarcoma. The majority of bleeding complications could be controlled with conservative management.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Vasc Interv Radiol

DOI

EISSN

1535-7732

Publication Date

June 2016

Volume

27

Issue

6

Start / End Page

846 / 851

Location

United States

Related Subject Headings

  • Young Adult
  • Ultrasonography, Interventional
  • Severity of Illness Index
  • Risk Factors
  • Retrospective Studies
  • Republic of Korea
  • Predictive Value of Tests
  • Odds Ratio
  • Nuclear Medicine & Medical Imaging
  • Multivariate Analysis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kang, T. W., Lee, M. W., Choi, D., An, C., Kim, M.-J., Joo, I., … Jung, S.-H. (2016). Safety of Percutaneous Biopsy for Hepatic Angiosarcoma: Results of a Multicenter Korean Survey. J Vasc Interv Radiol, 27(6), 846–851. https://doi.org/10.1016/j.jvir.2016.01.148
Kang, Tae Wook, Min Woo Lee, Dongil Choi, Chansik An, Myeong-Jin Kim, Ijin Joo, So Jung Lee, et al. “Safety of Percutaneous Biopsy for Hepatic Angiosarcoma: Results of a Multicenter Korean Survey.J Vasc Interv Radiol 27, no. 6 (June 2016): 846–51. https://doi.org/10.1016/j.jvir.2016.01.148.
Kang TW, Lee MW, Choi D, An C, Kim M-J, Joo I, et al. Safety of Percutaneous Biopsy for Hepatic Angiosarcoma: Results of a Multicenter Korean Survey. J Vasc Interv Radiol. 2016 Jun;27(6):846–51.
Kang, Tae Wook, et al. “Safety of Percutaneous Biopsy for Hepatic Angiosarcoma: Results of a Multicenter Korean Survey.J Vasc Interv Radiol, vol. 27, no. 6, June 2016, pp. 846–51. Pubmed, doi:10.1016/j.jvir.2016.01.148.
Kang TW, Lee MW, Choi D, An C, Kim M-J, Joo I, Lee SJ, Lim S, Park JG, Seo JW, Jung S-H. Safety of Percutaneous Biopsy for Hepatic Angiosarcoma: Results of a Multicenter Korean Survey. J Vasc Interv Radiol. 2016 Jun;27(6):846–851.
Journal cover image

Published In

J Vasc Interv Radiol

DOI

EISSN

1535-7732

Publication Date

June 2016

Volume

27

Issue

6

Start / End Page

846 / 851

Location

United States

Related Subject Headings

  • Young Adult
  • Ultrasonography, Interventional
  • Severity of Illness Index
  • Risk Factors
  • Retrospective Studies
  • Republic of Korea
  • Predictive Value of Tests
  • Odds Ratio
  • Nuclear Medicine & Medical Imaging
  • Multivariate Analysis